Market News for Gilead Sciences Inc (GILD)
Gilead Sciences has agreed to buy German clinical-stage biotechnology company Tubulis for up to $5 billion in a deal that bolsters the biopharmaceutical company's oncology pipeline....
WSJ - 4/7/2026 8:50:00 AM
More News for GILD
Stock Analysis for GILD
Related Stocks:
Gilead said on Tuesday it would acquire private Germany-based Tubulis GmbH for up to $5 billion, boosting the U.S. drugmaker's pipeline with a lucrative class of experimental cancer drugs referred to as "guided missiles"....
Reuters - 4/7/2026 8:23:25 AM
More News for GILD
Stock Analysis for GILD
Related Stocks:
